Wednesday, December 21, 2016

Recent Buy: More Medtronics (MDT)

On Dec 21, 2016, I bought another 50 shares of Medtronics (MDT) at $71.50. This gives me 100 shares total. This is an increase of $76 a year going forward. This makes my forward total income at $1,640.97.

I would love to top off UL if it can get back below $40. Am I crazy at buying near 20k top? you betcha. Remember when we hit 10K and it was a huge deal?

Merry Christmas/whatever you believe in and a Happy New Year or early Lunar New Year.

And if you don't celebrate any holiday go and enjoy some chinese turkey. 😁

Monday, December 12, 2016

Recent Buy: More Unilever

On December 12, 2016, I bought 25.1699 shares of Unilever (UL) at $39.73 per share for a total of $1000 in my Loyal3 Account. This increased by forward dividends by ~$30 (due to forex).

With the strong dollar and weak pound/euro, this would seem like a horrible investment. Sure I'm getting 3.5% but after forex it's lower due to the strong dollar. However, like all currencies the dollar can only be strong for so long. At some point someone will short the dollar or it will naturally swing the other way to undervalued. Until it swings I'll happily wait and hoard more UL. I am currently at 151 shares. My goal is to own 300 shares at below $40 cost basis with a 3.5% yield and catalyst for price growth. NSRGY is looking interesting as well.

Also does anyone have any information on AQN? I'm trying to research this thing but I would like some experts to chime in on this gem. 

My forward dividend stands at ~1377.64-1407.33 depending on UL distribution $0.35 vs $0.301.

Thursday, December 8, 2016

Recent Buy: Medtronics

Today on December 8, 2016, I bought 50 shares of Medtronics at $71.89 for a total of $3.601.35.


Medtronic plc manufactures and sells device-based medical therapies worldwide. The company’s Cardiac and Vascular Group segment offers pacemakers, implantable cardioverter defibrillators and cardiac resynchronization therapy devices, AF products, diagnostics and monitoring devices, and remote monitoring and patient-centered software; and heart valves, percutaneous coronary intervention stent products, surgical valve replacement and repair products, endovascular stent grafts, peripheral vascular intervention products, and products to treat superficial and deep venous diseases. 

Rationale: Rewards>risk

  1. Yield 2.4%
  2. Payout ration: 53% 
  3. P/E
    1. TTM: 23.95x
    2. Forward: 14.27x
  4. Why is it down? 
    1. From buying Covidien. 
    2. And slowing down of rising price of medical reimbursement. 
  5. Fair Value or discount?
    1. Simply Wall St 
      1. Fair value: $87.82
    2. S&P capital: 
      1. 4 star buy, 
      2. fair price $86. 
      3. One year target $87.
    3. Thompson Reuters: 
      1. Neutral 4 buy, 
        1. Low: $80
        2. Mean: $85.5
        3. High: 96
    4. Edward Jones: 
      1. Buy rating
      2. Fair Value: $80.58
    5. Yahoo Finance:
      1. One year target: $85.50
Tax issue

"Beginning with the dividend payable on April 15, 2015, payments will be subject to an Irish withholding tax of 20% of the amount of each dividend unless the shareholder that is beneficially entitled to the dividend is a resident of the United States or a resident of a country listed as a “relevant territory”, and has ensured that the required information is on file with their broker, bank, qualifying intermediary or transfer agent (see below for more detail). With these rules, the vast majority of Medtronic shareholders and beneficial owners are entitled to an exemption from DWT."

This increased my forward dividends by $76.00 to $1,374.42. My next buy will probably be more UL or another 50 shares of MDT at $70 to complete my position. I also have a 100 share buy order on JNJ at $100. If the JNJ buyout goes through we might see that $100 again. 

Disclaimer: these are my opinions. Also updated my portfolio page. I really need to learn how to do that google docs thing.